Credit: Shutterstock photoAvista Healthcare Public Acquisition, a blank check company formed by Avista to acquire a health care company, filed and announced terms for its IPO on Friday.
The New York, NY-based company plans to raise $300 million by offering 30 million shares at a price of $10 . At the proposed price, Avista Healthcare Public Acquisition would command a fully diluted market value of $375 million.
Avista Healthcare Public Acquisition was founded in 2015 and plans to list on the Nasdaq under the symbol AHPAU. Credit Suisse is the sole bookrunner on the deal. A pricing date has not yet been disclosed.
The article Blank check company Avista Healthcare Public Acquisition files and sets terms for $300 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.
Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO) or the Global IPO Fund (symbol: IPOSX) , may have investments in securities of companies mentioned.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
